Bausch Health Companies Inc.
BHC.TO
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.60% | 6.13% | 12.16% | 10.86% | 10.77% |
| Total Other Revenue | 33.33% | 19.23% | 12.00% | 14.29% | 9.09% |
| Total Revenue | 4.92% | 6.27% | 12.15% | 10.89% | 10.75% |
| Cost of Revenue | 9.53% | 3.12% | 11.72% | 10.79% | 9.97% |
| Gross Profit | 2.97% | 7.57% | 12.32% | 10.94% | 11.09% |
| SG&A Expenses | 9.25% | 7.09% | 18.88% | 17.02% | 9.74% |
| Depreciation & Amortization | -6.57% | -8.16% | 8.30% | 0.37% | 0.37% |
| Other Operating Expenses | -- | -- | -- | 200.00% | -- |
| Total Operating Expenses | 7.34% | 3.37% | 12.73% | 10.86% | 7.98% |
| Operating Income | -10.03% | 17.16% | 10.12% | 11.02% | 31.72% |
| Income Before Tax | 31.88% | 3,085.71% | 93.56% | -39.24% | 49.26% |
| Income Tax Expenses | 387.50% | 177.50% | 26.79% | -5.77% | -89.04% |
| Earnings from Continuing Operations | -11.69% | 308.51% | 75.92% | -103.70% | 63.16% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 115.38% | -162.50% | 75.00% | 1,200.00% | 62.50% |
| Net Income | 9.38% | 338.46% | 77.51% | -61.54% | 68.16% |
| EBIT | -10.03% | 17.16% | 10.12% | 11.02% | 31.72% |
| EBITDA | -7.27% | 7.78% | 8.93% | 6.47% | 13.37% |
| EPS Basic | 10.09% | 327.27% | 77.70% | -61.85% | 68.46% |
| Normalized Basic EPS | 77.78% | 50.78% | 33.67% | 87.17% | 42.69% |
| EPS Diluted | 10.09% | 327.27% | 77.70% | -61.14% | 68.46% |
| Normalized Diluted EPS | 77.78% | 50.78% | 33.67% | 87.22% | 42.69% |
| Average Basic Shares Outstanding | 0.76% | 4.92% | 0.82% | 0.85% | 0.96% |
| Average Diluted Shares Outstanding | 0.76% | 4.92% | 0.82% | 0.84% | 0.96% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |